Company Snapshot: KG  Print This Story  Email This Story  Save this Link View PR Newswire's RSS Feed  Blogs Discussing this News Release  Search Blogs that Mention this News Release  Click this link to view linked Bookmarking Services Click this link to view linked Blogging Services


King Pharmaceuticals Provides Details for Live Webcast and Conference Call Following Release of Fourth Quarter 2005 Earnings

    BRISTOL, Tenn., Feb. 23 /PRNewswire-FirstCall/ -- King Pharmaceuticals,
Inc. (NYSE: KG) reported today that the Company will provide a live internet
webcast and conference call following King's announcement of earnings for the
fourth quarter and year ending December 31, 2005.  As previously announced,
King plans to announce earnings for the fourth quarter and year ending
December 31, 2005 prior to the market open on Tuesday, February 28, 2006.
    Two Ways to Join the Live Event - Tuesday, February 28, 2006, 1:00 pm,
Eastern Standard Time

    Internet Webcast:
    Click the following link to register, then join the live event with the
same URL:

    http://hpbroadband.com/program.cfm?key=KingPharmaQ4Earnings

    Telephone Audio Conference:
    Call in to the telephone conference up to 15 minutes early:

    Toll free in the United States     800-903-0258
    Outside the US                     785-832-1508
    Passcode                           7HP6312

    Can't Make the Live Event?  Listen "On-Demand":
    If you are unable to participate during the live event, the call will be
archived on King's web site http://www.kingpharm.com for not less than 14 days
following the call.
    King, headquartered in Bristol, Tennessee, is a vertically integrated
branded pharmaceutical company. King, an S&P 500 Index company, seeks to
capitalize on opportunities in the pharmaceutical industry through the
development, including through in-licensing arrangements and acquisitions, of
novel branded prescription pharmaceutical products in attractive markets and
the strategic acquisition of branded products that can benefit from focused
promotion and marketing and product life-cycle management.

    This release contains forward-looking statements which reflect
management's current views of future events and operations, including, but not
limited to, statements pertaining to the anticipated date for release of the
Company's financial results for the fourth quarter and year ending December
31, 2005.  These forward-looking statements involve certain significant risks
and uncertainties, and actual results may differ materially from the forward-
looking statements.  Some important factors which may cause results to differ
include: dependence on King's ability to release the Company's financial
results for fourth quarter and year ending December 31, 2005 as currently
planned on February 28, 2006.  Other important factors that may cause actual
results to differ materially from the forward-looking statements are discussed
in the "Risk Factors" section and other sections of King's Form 10-K for the
year ended December 31, 2004 and Form 10-Q for the third quarter ended
September 30, 2005, which are on file with the Securities and Exchange
Commission.  King does not undertake to publicly update or revise any of its
forward-looking statements even if experience or future changes show that the
indicated results or events will not be realized.


SOURCE King Pharmaceuticals, Inc.




Back to Topback to top

Related links:
  • http://www.kingpharm.com
  • http://hpbroadband.com/program.cfm?key=KingPharmaQ4Earnings
    CONTACT:
    James E. Green, Executive Vice President,
    Corporate Affairs, +1-423-989-8125, or David E. Robinson, Senior
    Director, Corporate Affairs, +1-423-989-7045, both of King
    Pharmaceuticals, Inc.